clodronic acid has been researched along with Osseous Paget's Disease in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (56.25) | 18.7374 |
1990's | 10 (20.83) | 18.2507 |
2000's | 10 (20.83) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (2.08) | 2.80 |
Authors | Studies |
---|---|
Kanis, JA; McCloskey, E; Paterson, AH; Powles, T | 1 |
De Filippo, G; De Paola, V; Esposito, T; Fusco, P; Gennari, L; Gianfrancesco, F; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D; Strazzullo, P | 1 |
Brandi, ML; Ghinoi, V | 1 |
Boissier, S; Cabon, F; Clézardin, P; Colombel, M; Filleur, S; Fournier, P; Guglielmi, J | 1 |
Epstein, M; Joshua, F; Major, G | 1 |
Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R | 1 |
Abrahamsen, B; Brixen, KT; Kassem, MS; Mosekilde, L | 1 |
Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pantoja Hernández, CG; Pardo Romero, G; Pino Rivero, V; Trinidad Ruiz, G | 1 |
Douglas, DL; Duckworth, T; Kanis, JA; Prenton, MA; Preston, CJ; Preston, FE; Russell, RG; Woodhead, JS | 1 |
Chapuy, MC; Charhon, S; Meunier, PJ; Valentin-Opran, A | 1 |
Daly, M; Harris, ST; Neer, RM; Petkau, AJ; Potts, JT; Segre, GV; Tully, GL | 1 |
Beard, DJ; Cameron, EC; Douglas, DL; Kanis, JA; Paterson, AD; Preston, FE; Russell, RG | 1 |
Kovitz, KL; Krane, IM; Krane, SM; Simon, LS; Wortman, PD | 1 |
Chapuy, MC; Charhon, SA; Meunier, PJ | 1 |
Chapuy, MC; Delmas, PD; Meunier, PJ | 1 |
Adami, S; Guarrera, G; Lo Cascio, V; Marini, G; Rosini, S; Salvagno, G; Spiazzi, G | 1 |
Raisz, LG | 1 |
Alexandre, C; Bressot, C; Chapuy, MC; Edouard, C; Mathieu, L; Meunier, PJ; Trechsel, U; Vignon, E | 1 |
Beard, DJ; Douglas, DL; Duckworth, T; Kanis, JA; Preston, C; Russell, RG; Smith, TW; Underwood, I; Woodhead, JS | 1 |
Bijvoet, OL; de Vries, E; Frijlink, WB; Jie, K; Meijer, CJ; Mulder, H; Reitsma, PH; te Velde, J; van der Linden, H; van der Wey, JP; van Paassen, HC | 1 |
Charhon, S; Cheix, F; Meunier, PJ; Vauzelle, JL; Vergnon, JM | 1 |
Arlot, ME; Meunier, PJ | 1 |
Douglas, DL; Duckworth, T; Jefferson, AA; Kanis, JA; Martin, TJ; Russell, RG | 1 |
Fleisch, H; Jung, A | 1 |
Alexandre, C; Briancon, D; Chapuy, MC; Charhon, S; Delmas, PD; Edouard, C; Meunier, PJ; Vignon, E | 1 |
Goa, KL; Plosker, GL | 1 |
Alfano, FS; Basini, G; Campanini, C; Fantuzzi, M; Gatti, C; Girasole, G; Passeri, M; Pedrazzoni, M | 1 |
Eyres, KS; Fern, ED; Kanis, JA; Khan, S; McCloskey, EV | 2 |
Baratelli, E; Broggini, M; Cappelli, A; Ghiringhelli, D; Marconi, A; Salzillo, A | 1 |
Meunier, PJ; Vignot, E | 1 |
Coombes, G; Eyres, KS; Kanis, JA; Khan, SA; McCloskey, EV; Nakatsuka, K; Orgee, J; Sirtori, P | 1 |
Coombes, GM; Kanis, JA; Khan, SA; McCloskey, EV; Nakatsuka, K; Orgee, J | 1 |
Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G | 1 |
Ashford, RU; Dey, A; Kanis, JA; Kayan, K; McCloskey, EV; Pande, KC | 1 |
Cundy, T; Hassan, IM; Que, L; Rutland, M; Wattie, D | 1 |
Bartl, R | 1 |
Alexandre, C; Bressot, C; Chapuy, MC; Edouard, C; Mathieu, L; Meunier, PJ; Trechsel, U; Vignon, C | 1 |
Alexandre, C; Fischer, C; Meunier, P; Trillet, M | 1 |
Bickerstaff, DR; Burke, PH; Douglas, DL; Kanis, JA; O'Doherty, DP | 1 |
Beard, DJ; Beneton, M; Harris, S; Kanis, JA; Preston, CJ; Russell, RG | 1 |
Atkins, RM; Beneton, MN; Gray, RE; Hamdy, NA; Kanis, JA; Percival, RC; Preston, CJ; Russell, RG; Urwin, GH; Yates, AJ | 1 |
Adami, S; Garavelli, S; Guarrera, G; Lo Cascio, V; Montesanti, F; Rosini, S; Salvagno, G | 1 |
Bijvoet, OL; Blanksma, HJ; Dahlinghaus-Nienhuys, PJ; Harinck, HI | 1 |
Gray, RE; Kanis, JA; Preston, CJ; Russell, RG; Smith, R; Yates, AJ | 1 |
Petrovic, AG; Stutzmann, JJ | 1 |
Kanis, JA; Percival, RC; Watson, ME; Williams, JL | 1 |
Fleisch, H | 1 |
4 review(s) available for clodronic acid and Osseous Paget's Disease
Article | Year |
---|---|
Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.
Topics: Antimetabolites; Bone and Bones; Bone Diseases; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Drug Evaluation, Preclinical; Humans; Hyperkalemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans; Osteoporosis | 2002 |
[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Risedronic Acid | 2005 |
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose-Response Relationship, Drug; Half-Life; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Osteitis Deformans; Osteoporosis; Tissue Distribution | 1994 |
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Myositis Ossificans; Osteitis Deformans; Osteolysis; Osteoporosis; Pamidronate; Urinary Calculi | 1985 |
5 trial(s) available for clodronic acid and Osseous Paget's Disease
Article | Year |
---|---|
Bisphosphonate resistance in Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Injections, Intravenous; Middle Aged; Osteitis Deformans; Pamidronate | 2003 |
Short courses of intravenous clodronate in the treatment of Paget's disease of bone: a long-term follow-up trial.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus | 1993 |
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome | 1998 |
Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone | 1979 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteitis Deformans; Pamidronate; Remission Induction; Time Factors | 1987 |
39 other study(ies) available for clodronic acid and Osseous Paget's Disease
Article | Year |
---|---|
Clodronate.
Topics: Animals; Clodronic Acid; Diphosphonates; Hypercalcemia; Mice; Osteitis Deformans; Osteoclasts | 2021 |
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone.
Topics: Adaptor Proteins, Signal Transducing; Aged; Clodronic Acid; Cohort Studies; Drug Resistance; Exons; Female; Genetic Variation; Humans; Male; Middle Aged; Osteitis Deformans; Polymorphism, Genetic; Receptors, Calcitriol; Risk; Sequestosome-1 Protein | 2008 |
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Topics: Angiogenesis Inhibitors; Animals; Bone and Bones; Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; Endothelium, Vascular; Epithelial Cells; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Neovascularization, Physiologic; Orchiectomy; Osteitis Deformans; Prostate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Testosterone; Tissue Distribution; Zoledronic Acid | 2002 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome | 2004 |
[Association between primary hyperparathyroidism and Paget's disease. Report of a case].
Topics: Aged; Antimetabolites; Calcitonin; Clodronic Acid; Female; Humans; Hyperparathyroidism; Lumbar Vertebrae; Osteitis Deformans; Parathyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans | 1980 |
Intravenous etidronate for spinal cord dysfunction due to Paget's disease.
Topics: Aged; Clodronic Acid; Diphosphonates; Humans; Hydrocarbons, Chlorinated; Injections, Intravenous; Male; Methylene Chloride; Osteitis Deformans; Spinal Cord Compression; Thoracic Vertebrae | 1982 |
Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Diphosphonates; Edetic Acid; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Osteitis Deformans; Parathyroid Hormone | 1982 |
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Osteitis Deformans | 1983 |
Serum levels of type I and III procollagen fragments in Paget's disease of bone.
Topics: Antibody Specificity; Calcitonin; Clodronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Peptide Fragments; Procollagen; Radioimmunoassay; Time Factors | 1984 |
Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Time Factors | 1983 |
Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Osteitis Deformans | 1984 |
Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Kinetics; Male; Middle Aged; Osteitis Deformans | 1984 |
New diphosphonates to block bone resorption.
Topics: Animals; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Multiple Myeloma; Osteitis Deformans; Osteoclasts; Osteolysis; Osteomalacia; Propanolamines | 1980 |
Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Time Factors | 1980 |
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Humans; Hydroxyproline; Movement; Osteitis Deformans; Pain; Parathyroid Hormone; Phosphates | 1980 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Lymphocyte Activation; Osteitis Deformans; Pamidronate; Phagocytes; Rats; Zinc | 1980 |
[Multifocal sarcoma associated with Paget's disease of bone. Effects of dichloromethylene diphosphate (author's transl)].
Topics: Aged; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Ilium; Male; Osteitis Deformans; Osteosarcoma; Ulna | 1981 |
Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Uric Acid | 1981 |
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?
Topics: Adult; Aged; Calcitonin; Clodronic Acid; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Paralysis; Spinal Cord; Spinal Cord Compression | 1981 |
[Diphosphonates in the treatment of bone metastases].
Topics: Animals; Bone and Bones; Bone Neoplasms; Bone Resorption; Calcium; Carcinoma 256, Walker; Clodronic Acid; Diphosphonates; Humans; Neoplasm Transplantation; Neoplasms, Experimental; Osteitis Deformans; Osteolysis; Rats | 1981 |
Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Osteitis Deformans; Parathyroid Hormone; Radionuclide Imaging; Vitamin D | 1982 |
Acute effects of bisphosphonates on new and traditional markers of bone resorption.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alendronate; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteoporosis; Peptides; Time Factors | 1995 |
Effects of intravenous dichloromethylene bisphosphonate (CL2MBP) in the treatment of Paget's disease of bone.
Topics: Aged; Clodronic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Osteitis Deformans; Treatment Outcome | 1994 |
Assessment of optimum duration of therapy with oral dichloromethylene diphosphonate (clodronate) in the treatment of Paget's disease.
Topics: Administration, Oral; Clodronic Acid; Drug Administration Schedule; Humans; Osteitis Deformans; Remission Induction; Retrospective Studies | 1994 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone and Bones; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Risk Assessment; Skull | 1995 |
Comparison of three intravenous regimens of clodronate in Paget disease of bone.
Topics: Aged; Analysis of Variance; Clodronic Acid; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Infusions, Intravenous; Male; Osteitis Deformans; Retrospective Studies | 1996 |
Duration of response with oral clodronate in Paget's disease of bone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Analysis of Variance; Clodronic Acid; Drug Administration Schedule; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Regression Analysis; Remission Induction; Retreatment; Retrospective Studies | 1996 |
Atypical familial Paget's disease of bone.
Topics: Adult; Clodronic Acid; Female; Genetic Predisposition to Disease; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Radiography | 2001 |
Bisphosphonate space measurement and dosage requirement for intravenous clodronate treatment of Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Prospective Studies | 2002 |
[Bisphosphonate therapy in Paget disease?].
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Clodronic Acid; Drug Administration Schedule; Humans; Infusions, Intravenous; Male; Osteitis Deformans | 2002 |
[Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Topics: Aged; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Paraplegia | 1979 |
Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Cephalometry; Clodronic Acid; Diphosphonates; Etidronic Acid; Face; Female; Humans; Male; Middle Aged; Osteitis Deformans; Photogrammetry; Skull | 1990 |
Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Topics: Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Inclusion Bodies, Viral; Inosine; Inosine Pranobex; Osteitis Deformans | 1985 |
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Infusions, Parenteral; Osteitis Deformans; Recurrence | 1985 |
Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
Topics: Alendronate; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans | 1986 |
Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Etidronic Acid; Humans; Osteitis Deformans | 1987 |
Diphosphonates for otospongiosis.
Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Mandible; Mandibular Diseases; Middle Aged; Osteitis Deformans; Otosclerosis; Pamidronate | 1985 |
Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption.
Topics: Aged; Bone Neoplasms; Bone Resorption; Clodronic Acid; Drug Therapy, Combination; Humans; Male; Osteitis Deformans; Paralysis; Plicamycin; Prostatic Neoplasms | 1985 |